JAZZ vs ZD · P/E 1988, rev $2.28B vs P/E 38, rev $554.4M
Jazz Pharmaceuticals PLC (JAZZ) versus Ziff Davis Inc (ZD) — a side-by-side from cached financials, not a winner call.
Jazz Pharmaceuticals PLC (JAZZ) is a biotechnology company listed on US.
Ziff Davis Inc (ZD) is a advertising agencies company listed on NASDAQ.
Latest reported JAZZ revenue for 2026-06-30 was $2.28B. Net income was $485.9M. JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1.
Latest reported ZD revenue for 2026-06-30 was $554.4M. Net income was $646.7M. ZD currently screens at market cap $1.63B and trailing P/E 37.9.
JAZZ currently screens at market cap $14.97B and trailing P/E 1988.1. ZD currently screens at market cap $1.63B and trailing P/E 37.9.
Not investment advice. Open the JAZZ and ZD stock pages for the full models.
Not investment advice.